AKIN Classification for Acute Kidney Injury (AKI)
ورودیهای بالینی بیمار
حداقل ۰.۱ — حداکثر ۱۵ • واحد: mg/dL
حداقل ۰.۱ — حداکثر ۱۵ • واحد: mg/dL
حداقل ۰ — حداکثر ۱۰ • واحد: mg/dL
حداقل ۰ — حداکثر ۵۰ • واحد: mL/kg
حداقل ۰ — حداکثر ۱۰۰ • واحد: mL/kg
حداقل ۰ — حداکثر ۲۰۰ • واحد: mL/kg
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- No AKI0–0
- Stage 11–1
- Stage 22–2
- Stage 33–3
Clinical Decision Pathway
Clinical Decision Pathway & Next Steps
Renal Failure, Electrolytes & Dosing — نارسایی کلیه، الکترولیتها و تنظیم دوز
Clinical Rationale:
Estimate GFR with CKD-EPI 2021 and Cockcroft-Gault for pharmacokinetic dosing. Stage AKI with AKIN, differentiate prerenal azotemia with FENa and FEUrea, and correct calcium and free water deficits.
Creatinine Clearance (Cockcroft-Gault Equation)
کلیرانس کراتینین (کاکرافت-گالت)
Recommended Clinical Next Steps:
Fractional Excretion of Sodium (FENa)
دفع جزئی سدیم (FENa)
Why next: Prerenal azotemia vs acute tubular necrosisFractional Excretion of Urea (FEUrea)
دفع جزئی اوره (FEUrea)
Why next: Prerenal azotemia differentiation with diureticsCalcium Correction for Hypoalbuminemia and Hyperalbuminemia
اصلاح کلسیم سرم بر اساس آلبومین
Why next: Serum calcium correction for albumin
The AKIN Classification for Acute Kidney Injury (AKI) calculates estimating glomerular filtration rate (eGFR), staging renal disease, and adjusting drug clearances. Key inputs include baseline creatinine. Scores guide adjusting renal medication clearance, coordinating nephrology follow-up, or planning renal replacement therapy. Routine clinical application promotes standardized evidence-based patient management.
Clinical Guidelines & Evidence
Classifies severity of acute kidney injury based on serum creatinine and urine output criteria within 48 hours
Clinical Indication
The AKIN Classification for Acute Kidney Injury (AKI) is indicated for bedside clinical practice to support Classifies severity of acute kidney injury based on serum creatinine and urine output criteria within 48 hours. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with acute kidney injury (AKI), chronic kidney disease stages 1-5, or acid-base and fluid-electrolyte disturbances. Clinical application is indicated across Nephrology clinics, hemodialysis units, acute inpatient renal services, and metabolic wards.
Limitations & Contraindications
eGFR estimation equations assume steady-state serum creatinine and become unreliable during unstable AKI, amputations, or extremes of muscle mass. Clinical exclusion: Diagnosis requires adequate hydration and exclusion of urinary obstruction.
Clinical Pearls & Action Plan
Serum creatinine lags behind acute reductions in glomerular filtration; monitor hourly urine output and consider cystatin C in evolving AKI.
Stage 1: Cr ≥0.3 mg/dL increase or 1.5-2x baseline OR UO <0.5 mL/kg/hr x >6h; Stage 2: Cr 2-3x baseline OR UO <0.5 mL/kg/hr x >12h; Stage 3: Cr >3x baseline or ≥4.0 mg/dL with acute increase ≥0.5 mg/dL OR UO <0.3 mL/kg/hr x ≥24h or anuria x 12h OR RRT
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| baseline_creatinine | float | No | Baseline serum creatinine in mg/dL (if known)(mg/dL) |
| current_creatinine | float | Yes | Current serum creatinine in mg/dL(mg/dL) |
| creatinine_increase | float | No | Absolute increase in creatinine from baseline in mg/dL (if baseline known)(mg/dL) |
| urine_output_6h | float | No | Urine output over 6 hours in mL/kg(mL/kg) |
| urine_output_12h | float | No | Urine output over 12 hours in mL/kg(mL/kg) |
| urine_output_24h | float | No | Urine output over 24 hours in mL/kg(mL/kg) |
| anuria_12h | string | No | Anuria (no urine output) for 12 hours |
| on_rrt | string | No | Patient on renal replacement therapy (automatically Stage 3) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–0 | No AKI | No acute kidney injury |
| 1–1 | Stage 1 | Mild AKI |
| 2–2 | Stage 2 | Moderate AKI |
| 3–3 | Stage 3 | Severe AKI |
Evidence-Based References (EBM)
- Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11(2):R31.
- Lopes JA, Jorge S. The RIFLE and AKIN classifications for acute kidney injury: a critical and comprehensive review. Clin Kidney J. 2013;6(1):8-14.
- Xiong J, Tang X, Hu Z, et al. The RIFLE versus AKIN classification for incidence and mortality of acute kidney injury in critical ill patients: A meta-analysis. Sci Rep. 2015;5:17917.